Torsten Haack
34Patents
5h-index
33Co-inventors
65Inventor score
Filing activity: Aug 14, 2008 → Aug 8, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9181305B2 | Exendin-4 peptide analogues | Emerging Cross-Sectional Technologies | 20 | Active |
| US9750788B2 | Non-acylated exendin-4 peptide analogues | Chemistry; Metallurgy | 10 | Active |
| US9365632B2 | Exendin-4 derivatives as dual GLP1/glucagon agonists | Emerging Cross-Sectional Technologies | 6 | Active |
| US9758561B2 | Dual GLP-1/glucagon receptor agonists derived from exendin-4 | Human Necessities | 5 | Active |
| US9745360B2 | Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonists | Emerging Cross-Sectional Technologies | 5 | Active |
| US8828994B2 | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof | Chemistry; Metallurgy | 4 | Active |
| US9789165B2 | Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists | Chemistry; Metallurgy | 3 | Active |
| US9771406B2 | Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4 | Chemistry; Metallurgy | 3 | Active |
| US9775904B2 | Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists | Chemistry; Metallurgy | 3 | Active |
| US9751926B2 | Dual GLP-1/GIP receptor agonists | Chemistry; Metallurgy | 3 | Active |
| US9694053B2 | Dual GLP-1/glucagon receptor agonists | Chemistry; Metallurgy | 3 | Active |
| US9670261B2 | Functionalized exendin-4 derivatives | Emerging Cross-Sectional Technologies | 2 | Active |
| US10519211B2 | Compounds as peptidic GLP1/glucagon/GIP receptor agonists | Chemistry; Metallurgy | 1 | Active |
| US9982029B2 | Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists | Human Necessities | 1 | Active |
| US8853208B2 | Amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments | Chemistry; Metallurgy | 0 | Active |
| US11046743B2 | Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes | Emerging Cross-Sectional Technologies | 0 | Active |
| US8901114B2 | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof | Chemistry; Metallurgy | 0 | Active |
| US8710050B2 | Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof | Chemistry; Metallurgy | 0 | Active |
| US8828991B2 | Azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments | Chemistry; Metallurgy | 0 | Active |
| US8822495B2 | Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | Chemistry; Metallurgy | 0 | Active |
| US8809324B2 | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof | Chemistry; Metallurgy | 0 | Active |
| US9932381B2 | Exendin-4 derivatives as selective glucagon receptor agonists | Human Necessities | 0 | Active |
| US8828995B2 | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof | Chemistry; Metallurgy | 0 | Active |
| US10538567B2 | Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists | Human Necessities | 0 | Active |
| US11352405B2 | GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.